UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pineapple extract gel approved for burns
Nexoberide Gel, a treatment that removes dead skin tissues caused by burns,...
by Lee Hye-seon
|
2018-05-19 08:19
라인
Is Sanofi already gunning for expanded coverage after gaining reimbursement?
A British expert has stressed the importance of combining both early hormon...
by Nam Doo-hyun
|
2018-05-18 16:02
라인
Theragen dismisses allegations against its drug substance
Theragen Etex Bio Institute denied recent allegations regarding the problem...
by Lee Han-soo
|
2018-05-18 11:09
라인
Sillajen unveils trial results for cancer treatment at US conference
Sillajen said Thursday that it has presented partial sections of its phase ...
by Lee Han-soo
|
2018-05-17 18:01
라인
Sanofi Genzyme Korea gets 2nd line coverage for prostate cancer drug
Sanofi Genzyme Korea said Thursday that it got reimbursement for its prosta...
by Marian Chu
|
2018-05-17 18:01
라인
Samsung BioLogics shares fall 4% ahead of FSC review over alleged accounting fraud
Shares of Samsung BioLogics fell 4 percent as officials from Samsung BioLog...
by Marian Chu
|
2018-05-17 18:00
라인
Ildong, Olix agree to develop macular degeneration treatment
Ildong said Thursday that it has signed a cooperative agreement with Olix P...
by Lee Han-soo
|
2018-05-17 14:18
라인
Hugel completes P1 clinical trial on hypertrophic scar treatment
Hugel said Wednesday that it has completed phase 1 clinical trials on BMT10...
by Lee Han-soo
|
2018-05-17 11:50
라인
Dongwha, Hugel boost Q1 earnings under new CEO
Seven drugmakers with new CEOs this year showed mixed results in the first-...
by So Jae-hyeon
|
2018-05-17 11:45
라인
Allergan Korea appoints Kim Ji-hyun as new CEO
Allergan appointed Kim Ji-hyun as the new CEO of its Korean offshoot. Kim h...
by Marian Chu
|
2018-05-17 11:36
라인
US approves Daewoong’s Nabota plant
Daewoong Pharmaceutical said it got the U.S. Food and Drug Administration’s...
by Marian Chu
|
2018-05-16 18:34
라인
‘Biosimilars are better than originals’
“Biosimilars offer better quality than original drugs. This is a fact.”Jean...
by Park Gi-taek
|
2018-05-16 15:56
라인
Jeil Pharma opens new tech research center
Jeil Pharmaceutical said Wednesday that it has opened a new technology rese...
by Lee Han-soo
|
2018-05-16 14:14
라인
Warm inter-Korean relations may benefit GC Pharma, Dong-A ST
The South Korean pharmaceutical industry is paying keen attention to which ...
by So Jae-hyeon
|
2018-05-15 15:50
라인
Dongkook to export hyaluronic acid filler to China
Dongkook Pharmaceutical said Monday that it has signed a 16 billion won ($1...
by Lee Han-soo
|
2018-05-15 15:21
라인
Huons Global posts ₩85.8 billion in Q1 sales
Huons Global said Tuesday the company and its subsidiaries recorded 85.8 bi...
by Lee Han-soo
|
2018-05-15 14:59
라인
Medytox posts ₩58.8 billion in Q1 sales
Medytox said Tuesday that it recorded 58.8 billion won ($54.9 million) in s...
by Lee Han-soo
|
2018-05-15 14:59
라인
Merck’s Erbitux extends RSA status
Merck Korea and the health authorities have renewed their risk-sharing agre...
by Nam Doo-hyun
|
2018-05-15 14:31
라인
Alteogen to launch global P1 trial of Eylea biosimilar in 2019
Alteogen has wrapped up the pre-clinical trial for ALT-L9 - an Eylea biosim...
by Marian Chu
|
2018-05-15 11:26
라인
Ildong wins nod for hypertension treatment
Ildong Pharmaceutical said Monday that it has received sales approval for T...
by Lee Han-soo
|
2018-05-14 16:50
-
이전
81
82
83
84
85
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top